MedTech Color has announced its top 10 finalists from the 2025 MedTech Innovator Road Tour, recognizing early-stage companies with promising innovations in health equity and diversity-focused medical technology.
Selected by a panel of industry judges, the finalists pitched to investors and medtech leaders and received top scores based on innovation, potential impact, and presentation. Each finalist receives a complimentary membership in MedTech Color and access to in-kind prizes from partner organizations as part of their recognition, the organization said in a LinkedIn post.
The 2025 MedTech Color Top 10 finalists are:
- Moses Cesario, Butterfly Biosciences
- Rachel Zayas-Schwartz, AGED Diagnostics
- Amelia Z., BioLattice
- Oluwagbebemi Oyeniyi, Dialysis-X
- Kehlin Swain, Greens Health
- Nanette Sene, Juno Technologies
- Hannah McKenney, Starling (YC W22)
- Oke Anakwenze, SutureTech
- Young Juhn, Wellysis
- Andrew Ortega-Verdaguer, IntelVasc
The pitch competition is part of MedTech Color’s broader mission to support and amplify diverse innovators in the medtech industry. The finalists were selected from a national pool of entrepreneurs advancing solutions across diagnostics, therapeutics, and digital health.
The program is supported by sponsors including Medmarc, Johnson & Johnson, and Wilson Sonsini.
MedTech Color is expected to provide additional exposure and opportunities for these companies as they continue toward commercialization and future fundraising.
